Volatility May Only Get Worse

Image Source: TradingView.com This article was sent to members via email December 21. You can access that email at the link that follows this article. By Brian Nelson, CFA Good morning folks, Boy is it good to be back in the full swing of things.  Writing Value Trap: Theory of Universal Valuation took almost everything out of me the past few months, but it was absolutely necessary. This book challenges the greatest thinkers in finance, and its 350 pages are chock-full of footnotes and examples, complete with a Preface, Notes, Bibliography and 18-page index. I think you’re going to love it, and what’s more, if you have questions about it, you can reach out to me for further explanation! Yesterday was another … Read more

Market Looks Vulnerable

Image Source: TradingView.com This article was sent to members via email December 20. You can access that email via the link that follows this article. By Brian Nelson, CFA Hi everyone, It’s time to start thinking about portfolio protection. It looks like the S&P 500 broke below technical levels, and I would not be surprised to see heightened volatility heading into the close of this year into next. This December has been one of the worst months in history, but I feel like 2019 may become one of our worst years in history. That doesn’t mean you should panic, but you should reset your expectations lower. This market is looking treacherous. Just when it looked like Facebook (FB) was getting … Read more

Stock Market Technical Breakdown

Image Source: TradingView.com This article was sent to members via email December 18. You can access that email via the link that follows this article. By Brian Nelson, CFA Hi everyone, I’m getting a bit concerned about the technical backdrop of the market, and while fundamentals certainly aren’t poor, it is changes in future fundamental *expectations* that drive prices.  My book will hammer this point home: if the conversation is about last year’s data and not about how you arrived at your fair value estimate, efforts are lost before they begin. In evaluating the past data, often ambiguous valuation multiples, you’re evaluating something that is non-causal to returns, and therefore cannot be predictive of returns. Future expectations of enterprise free … Read more

Shale and LNG Drive Upstream Production at Chevron

Image Source: Author’s Calculations, Chevron Investor Relations From 2010 to 2017, Chevron’s oil and gas production dropped as output from new producing properties was more than offset by declines at mature fields. By leveraging the company’s extensive unconventional growth runway, management appears to have been able to fix a key structural problem. The revival in Chevron’s upstream production was aided by the completion of two major LNG developments in Australia that offer near-term upside. By Callum Turcan Shares of Chevron Corp (CVX) yield 4.3% as of this writing, and the image above shows annual per share dividend increases from the company since 2010. Its Dividend Cushion ratio currently sits at 1.2. As oil prices followed a generally positive trend from … Read more

Parting with Altria on News of Stake in JUUL

Image shown: Altria’s performance during the past couple years. Tobacco giant Altria is working to expand its long-term growth potential away from the secular decline in cigarette volumes via an investment in the leading US e-cigarette company. Unfortunately, we think its large investment in JUUL has put the pace of its dividend growth at risk, and we’re parting with this long-term winner in both simulated newsletter portfolios. We’re also putting Altria’s fair value estimate under review, and we expect to lower it materially in an updated report to be published after the holidays. Technical weakness has also put a damper on our excitement. By Kris Rosemann and Brian Nelson, CFA We’re parting ways in both the simulated Best Ideas Newsletter … Read more

Dividend Increases/Decreases for the Week Ending December 21

Below we provide a list of firms that raised their dividends during the week ending December 21. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Abbot Laboratories (ABT): now $0.32 per share quarterly dividend, was $0.28. ABM Industries (ABM): now $0.18 per share quarterly dividend, was $0.175. Alamo (ALG): now $0.12 per share quarterly dividend, was $0.11. ALPS Alerian Energy Infrastructure ETF (ENFR): now $0.1863 per share quarterly dividend, was $0.17. ALPS Cohen & Steers Global Realty Majors ETF (GRI): now $0.4095 per share quarterly dividend, was $0.22. ALPS Equal Sector … Read more

Market Mayhem — Alerts for Members

During these extremely volatile times, it’s important to stay focused. On December 15, we informed all of our members to “Pay Attention.” Shortly thereafter, we notified members of the potential for a stock market technical breakdown. This morning, we offered a pre-market briefing about the importance of thinking about portfolio protection. For Best Ideas Newsletter and Dividend Growth Newsletter members: http://campaign.r20.constantcontact.com/render?preview=true&m=1110817109903&ca=e2406cd6-c113-4344-8731-493f33fc44a4&id=preview For High Yield Dividend Newsletter members: http://campaign.r20.constantcontact.com/render?preview=true&m=1110817109903&ca=b3ba530f-38b3-489a-ac96-2961dca89c6b&id=preview For Exclusive members: http://campaign.r20.constantcontact.com/render?preview=true&m=1110817109903&ca=ba6d90c0-4433-48b2-9b8a-aac4ddf9006e&id=preview We’re here for any questions. Please just let us know how we can help! Kind regards, Brian Nelson, CFA  brian@valuentum.com

Oracle Raises Internal Guidance; Share Buybacks Abound

Image Source: May Wong Oracle’s fiscal 2019 second quarter report revealed expectations for accelerating top-line growth thanks in large part to strong momentum in bookings. The company’s technology leadership may be greater than ever before, and it continues to generate robust free cash flow. Management’s appetite for buybacks appears insatiable. By Kris Rosemann Simulated Dividend Growth Newsletter portfolio idea Oracle (ORCL) released its fiscal 2019 second quarter report December 18, and management brought with it an increase in its internal expectations for top- and bottom-line growth for the full fiscal year. On the quarterly conference call, CEO Safra Catz stated expectations for an acceleration of constant currency revenue growth in the second half of the fiscal year, and the company’s … Read more

In the News: Healthcare Uncertainty, Housing Confidence Drops, and Banks Reel in Risk

Let’s take a look at some of the top stories impacting the markets, including the heightened uncertainty surrounding healthcare legislation, the drop in the NAHB Housing Market Index, and measures being taken by banks to limit exposure to risky counterparties. By Kris Rosemann Shares of health insurers and health care providers (XLV) are facing notable selling pressure December 17 after a federal judge in Texas ruled the Affordable Care Act is unconstitutional without the penalty for lack of insurance coverage, which was repealed by Congress last year. The ruling came on the evening of December 14, but it is almost certain to be appealed. The Affordable Care Act has been beleaguered for some time now, and the latest news casts … Read more

Repub: Johnson & Johnson’s Litigation Risk Manageable

Image Source: Austin Kirk This article was previously published June 6, 2018. Let’s talk about how to think about the impact of one-time events on intrinsic value estimates. The magnitude of damages against J&J with respect to its talcum-powder products could be large, but we think the market has slowly factored in the risk of legal liabilities. Once J&J puts these troubles behind it, we think the market may once again warm up to the equity. Shares are trading at only a modest discount to our intrinsic value estimate, however. By Brian Nelson, CFA A member of ours passed along a number of articles discussing litigation risk at Johnson & Johnson (JNJ) with respect to the company’s talcum powder products, … Read more